Inventor · disambiguated record
Diego Broggini
Also filed as: BROGGINI DIEGO · BROGGINI DIEGO F · BROGGINI DIEGO FERNANDO DOMENICO
18 granted patents·6 pending applications·42 citations·filing 2009–2023
91Inventor score
Files withJANSSEN PHARMACEUTICA NV10ASTEX THERAPEUTICS LTD5BROGGINI DIEGO3BRISTOL MYERS SQUIBB CO2CESCO-CANCIAN SERGIO2
Top patents by PatentIndex Score
24 records- 0191US9902714B2Quinoxaline derivatives useful as FGFR kinase modulatorsASTEX THERAPEUTICS LTD·Filed 2015·Granted Feb 27, 2018·15 cites·22 claims
- 0289US10898482B2Pharmaceutical compositions comprising N-(3,5-dimethoxyphenyl)-N'-1 methylethyl)-N-[3-(1-methyl-1H-pyrazol-4-yl)quinoxalin-6-yl]ethane-1,2-diamineASTEX THERAPEUTICS LTD·Filed 2016·Granted Jan 26, 2021·7 cites·66 claims
- 0387US10421747B2Quinoxaline derivatives useful as FGFR kinase modulatorsASTEX THERAPEUTICS LTD·Filed 2017·Granted Sep 24, 2019·6 cites·19 claims
- 0476US9518021B2Process for the preparation of histamine H3 receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Dec 13, 2016·1 cites·28 claims
- 0576US8921550B2Process for the preparation of benzoimidazol-2-yl pyrimidine derivativesMANI NEELAKANDHA S·Filed 2012·Granted Dec 30, 2014·3 cites·1 claims
- 0676US8748596B2Process for the preparation of histamine H3 receptor modulatorsBROGGINI DIEGO·Filed 2010·Granted Jun 10, 2014·2 cites·2 claims
- 0776US8541614B2Process for the preparation of (−)-(4-chloro-phenyl)-(3-trifluoromethyl-phenoxy)-acetic acid 2-acetylamino-ethyl esterBROGGINI DIEGO·Filed 2009·Granted Sep 24, 2013·3 cites·27 claims
- 0875US7939527B2Thiazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amines as modulators of leukotriene A4 hydrolaseJANSSEN PHARMACEUTICA NV·Filed 2009·Granted May 10, 2011·2 cites·37 claims
- 0975US2024000778A1Pharmaceutical compositions comprising n-(3,5-dimethoxyphenyl)-n'-(1-methylethyl)-n-[3-(1-methyl-1h-pyrazol-4-yl)quinoxalin-6-yl]ethane-1,2-diamineASTEX THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 1073US8835633B2Process for the preparation of benzoimidazol-2-yl pyrimidine derivativesCESCO-CANCIAN SERGIO·Filed 2012·Granted Sep 16, 2014·2 cites·11 claims
- 1170US11684620B2Pharmaceutical compositions comprising N-(3,5-dimethoxyphenyl)-N′-(1-methylethyl)-N-[3-(1-methyl-1H-pyrazol-4-yl)quinoxalin-6-yl]ethane-1,2-diamineASTEX THERAPEUTICS LTD·Filed 2020·Granted Jun 27, 2023·0 cites·87 claims
- 1269US9371311B2Benzoimidazol-2-yl pyrimidine derivativesJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jun 21, 2016·1 cites·1 claims
- 1368US2023203011A1BI-Heteroaryl Substitute 1,4-Benzodiazepines And Uses Thereof For The Treatment Of CancerJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 1461US10323002B2Process for the preparation of histamine H3 receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Jun 18, 2019·0 cites·2 claims
- 1561US2010029942A1Process for the preparation of benzoimidazol-2-yl pyrimidine derivativesCESCO-CANCIAN SERGIO·Filed 2009·Application pending·0 cites
- 1659US9809547B2Process for the preparation of histamine H3 receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Nov 7, 2017·0 cites·1 claims
- 1754US11542247B2Bi-heteroaryl substitute 1,4-benzodiazepines and uses thereof for the treatment of cancerJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Jan 3, 2023·0 cites·25 claims
- 1853US12378246B2Synthetic options towards the manufacture of (6R,10S)-10-{4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-6-oxo-1(6H)-pyrimidinyl} - 1-(difluoromethyl)-6-methyl-1,4,7,8,9,10-hexahydro-11,15-(metheno)pyrazolo[4,3-b][1,7]diazacyclotetradecin-5(6H)-oneBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Aug 5, 2025·0 cites·13 claims
- 1953US10100035B2Substituted 2-[3-(1-methyl-piperidin-4-yl)-propylamino]-pyrimidine-5-carboxylic acids and amides and methods of making the sameJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Oct 16, 2018·0 cites·4 claims
- 2051US9796699B2Substituted 2-[3-(1-methyl-piperidin-4-yl)-propylamino]-pyrimidine-5-carboxylic acids and amides and methods of making the sameJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Oct 24, 2017·0 cites·17 claims
- 2148US2012232302A1Process for the Preparation of (-)-(4-Chloro-Phenyl)-(3-Trifluoromethyl-Phenoxy)-Acetic Acid 2-Acetylamino-Ethyl EsterBROGGINI DIEGO·Filed 2012·Application pending·0 cites
- 2248US2023416252A1Process toward the manufacture of (6r,10s)-10-{4-[5-chloro-2-(4-chloro-1h-1,2,3-triazol-1-yl)phenyl]-6-oxo-1(6h)-pyrimidinyl}- 1-(difluoromethyl)-6-methyl-1,4,7,8,9,10-hexahydro-11,15-(metheno)pyrazolo[4,3-b][1,7]diazacyclotetradecin-5(6h)-oneBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 2345US2016075636A1Process for the Preparation of (-)-(4-Chloro-Phenyl)-(3-Trifluoromethyl-Phenoxy)-Acetic Acid 2-Acetylamino-Ethyl EsterCYMABAY THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 2442US11155555B2CompoundsJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Oct 26, 2021·0 cites·18 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →